GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » Total Current Liabilities

Trajan Group Holdings (ASX:TRJ) Total Current Liabilities : A$40.3 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Trajan Group Holdings's total current liabilities for the quarter that ended in Dec. 2023 was A$40.3


Trajan Group Holdings Total Current Liabilities Historical Data

The historical data trend for Trajan Group Holdings's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings Total Current Liabilities Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23
Total Current Liabilities
24.11 80.15 39.20

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Current Liabilities Get a 7-Day Free Trial 38.41 80.15 43.46 39.20 40.35

Trajan Group Holdings Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Trajan Group Holdings's Total Current Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=16.781+11.762
+Other Current Liabilities+Current Deferred Liabilities
=9.196+1.457
=39.2

Trajan Group Holdings's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=14.674+16.737
+Other Current Liabilities+Current Deferred Liabilities
=8.731+0.203
=40.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Trajan Group Holdings Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Trajan Group Holdings (ASX:TRJ) Business Description

Traded in Other Exchanges
N/A
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Trajan Group Holdings Ltd operates in the analytical science industry. The group operates in two segments namely, Analytical Products which design, manufacture, distribute, and sale of Analytical components and consumables, and Life Science Solutions which design, manufacture, distribute, and sale of pathology, automation workflow solutions, microsampling devices, testing, and data analysis. The majority of its revenue is derived from developing and manufacturing a range of precision consumable components and solutions. It operates predominantly in Malaysia, Japan, Australia, New Zealand, the USA, Europe, the Middle East, India and African countries.

Trajan Group Holdings (ASX:TRJ) Headlines

No Headlines